ANVS Earnings

Quarterly EPS
$-0.97
Q3 2024
$-0.42
Q4 2024
$-0.32
Q1 2025
$-0.32
Q2 2025
$-0.37
Q3 2025
$-0.38
Q4 2025
$-0.63
Q1 2026
$-0.40
Q2 2026
Latest RevenueN/A
Latest Net Income-14820815
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.400-14820815-25.0%
Q1 2026-$0.630-17606382-96.9%
Q4 2025-$0.380-9834412+9.5%
Q3 2025-$0.370-7262658+61.9%
Q2 2025-$0.320-6220058+27.3%
Q1 2025-$0.320-5537069-220.0%
Q4 2024-$0.420-5864659+81.3%
Q3 2024-$0.970-12638357+40.5%
Q2 2024-$0.440-5020412
Q1 2024-$0.100-1066947
Q4 2023-$2.240-22213394
Q3 2023-$1.630-14716616
Annovis Bio (ANVS) — Earnings